JAMA editor won't ban authors for nondisclosure
On the advice of attorneys, the editor of the Journal of the American Medical Association says she won't ban authors who fail to disclose their financial ties to the drug industry, as a ban might spur antitrust suits. A ban "would only encourage that author to send his or her articles to another journal; it cleans our house by messing others," says Catherine DeAngelis, who has been highlighting cases of authors who fail to adhere to JAMA's disclosure rules. Critics who had been calling for a ban immediately launched new assaults on JAMA, saying it was refusing to enforce even basic standards of conduct by authors.
- here's the article on JAMA from NewsTarget.com
More stories about critics American Medical Association spur Journal of the American Medical Association
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

